Review: could Remicade cause Systemic Sclerosis (scleroderma)?


Systemic sclerosis (scleroderma) is found among people who take Remicade, especially for people who are female, 50-59 old , have been taking the drug for < 1 month, also take medication Methotrexate, and have Rheumatoid arthritis . We study 117,001 people who have side effects while taking Remicade from FDA and social media. Among them, 37 have Systemic sclerosis (scleroderma). Find out below who they are, when they have Systemic sclerosis (scleroderma) and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Remicade has active ingredients of infliximab. It is often used in crohn's disease. (latest outcomes from Remicade 120,130 users)

Systemic Sclerosis (scleroderma)

Systemic sclerosis (scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin) has been reported by people with primary pulmonary hypertension, pulmonary hypertension, systemic sclerosis (scleroderma), rheumatoid arthritis, osteoporosis (latest reports from 6,011 Systemic sclerosis (scleroderma) patients).

On Sep, 19, 2016

117,001 people reported to have side effects when taking Remicade.
Among them, 37 people (0.03%) have Systemic Sclerosis (scleroderma)

Number of reports submitted per year:

Could Remicade cause Systemic sclerosis (scleroderma)?

Time on Remicade when people have Systemic Sclerosis (scleroderma) *:

  • < 1 month: 66.67 %
  • 1 - 6 months: 22.22 %
  • 6 - 12 months: 11.11 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Systemic Sclerosis (scleroderma) when taking Remicade *:

  • female: 71.43 %
  • male: 28.57 %

Age of people who have Systemic Sclerosis (scleroderma) when taking Remicade *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.55 %
  • 30-39: 13.64 %
  • 40-49: 18.18 %
  • 50-59: 45.45 %
  • 60+: 18.18 %

Top conditions involved for these people *:

  • Rheumatoid Arthritis (12 people, 32.43%)
  • Crohn's Disease (6 people, 16.22%)
  • Ankylosing Spondylitis (4 people, 10.81%)
  • Prophylaxis (2 people, 5.41%)
  • Eosinophilic Fasciitis (2 people, 5.41%)

Top co-used drugs for these people *:

  • Methotrexate (7 people, 18.92%)
  • Prednisone (4 people, 10.81%)
  • Neurontin (4 people, 10.81%)
  • Wellbutrin (3 people, 8.11%)
  • Bextra (3 people, 8.11%)

Top other side effects for these people *:

  • Infusion Related Reaction (8 people, 21.62%)
  • Interstitial Lung Disease (6 people, 16.22%)
  • Rash (3 people, 8.11%)
  • Laryngeal Oedema (3 people, 8.11%)
  • Arrhythmia (3 people, 8.11%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Systemic sclerosis (scleroderma) when taking Remicade?

Browse all side effects of Remicade

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Systemic sclerosis (scleroderma)

Systemic sclerosis (scleroderma)

Could your condition cause Systemic sclerosis (scleroderma)

Systemic sclerosis (scleroderma)

Related studies

Can you answer these questions?

More questions for: Remicade, Systemic sclerosis (scleroderma)

You may be interested in these reviews

More reviews for: Remicade, Systemic sclerosis (scleroderma)

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.